Syneos Health, a fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract Commercial Organization), has agreed to acquire Synteract, a full-service CRO focused on the rapidly growing emerging biopharma segment.   Synteract provides deep therapeutic expertise in oncology, rare and orphan diseases, neuroscience, dermatology, and pediatrics. Its client base comprises primarily pre-revenue companies, a segment in which Syneos Heal...